167 related articles for article (PubMed ID: 24417657)
1. Mimicking red blood cell lipid membrane to enhance the hemocompatibility of large-pore mesoporous silica.
Roggers RA; Joglekar M; Valenstein JS; Trewyn BG
ACS Appl Mater Interfaces; 2014 Feb; 6(3):1675-81. PubMed ID: 24417657
[TBL] [Abstract][Full Text] [Related]
2. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
3. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Lin YS; Haynes CL
J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
[TBL] [Abstract][Full Text] [Related]
4. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
5. Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes.
Chen ZA; Wu SH; Chen P; Chen YP; Mou CY
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4790-4798. PubMed ID: 30624037
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells.
Abbaraju PL; Meka AK; Song H; Yang Y; Jambhrunkar M; Zhang J; Xu C; Yu M; Yu C
J Am Chem Soc; 2017 May; 139(18):6321-6328. PubMed ID: 28440642
[TBL] [Abstract][Full Text] [Related]
7. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic.
Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A
Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198
[TBL] [Abstract][Full Text] [Related]
8. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems.
Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A
Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
[TBL] [Abstract][Full Text] [Related]
10. Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis.
Ma Z; Bai J; Wang Y; Jiang X
ACS Appl Mater Interfaces; 2014 Feb; 6(4):2431-8. PubMed ID: 24460090
[TBL] [Abstract][Full Text] [Related]
11. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
12. Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.
Farooq A; Shukur A; Astley C; Tosheva L; Kelly P; Whitehead D; Azzawi M
Acta Biomater; 2018 Aug; 76():208-216. PubMed ID: 29933106
[TBL] [Abstract][Full Text] [Related]
13. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
Roggers RA; Lin VS; Trewyn BG
Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
[TBL] [Abstract][Full Text] [Related]
14. Enriched Au nanoclusters with mesoporous silica nanoparticles for improved fluorescence/computed tomography dual-modal imaging.
Yuan Y; Zhou R; Li T; Qu S; Bai H; Liang J; Cai X; Guo B
Cell Prolif; 2021 Apr; 54(4):e13008. PubMed ID: 33634540
[TBL] [Abstract][Full Text] [Related]
15. Facile preparation of ultra-large pore mesoporous silica nanoparticles and their application to the encapsulation of large guest molecules.
Shin HS; Hwang YK; Huh S
ACS Appl Mater Interfaces; 2014 Feb; 6(3):1740-6. PubMed ID: 24447071
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
17. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of hollow mesoporous silica nanoparticles with tunable shell thickness and pore size using amphiphilic block copolymers as core templates.
Zhou X; Cheng X; Feng W; Qiu K; Chen L; Nie W; Yin Z; Mo X; Wang H; He C
Dalton Trans; 2014 Aug; 43(31):11834-42. PubMed ID: 24957865
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
Lin CH; Cheng SH; Liao WN; Wei PR; Sung PJ; Weng CF; Lee CH
Int J Pharm; 2012 Jun; 429(1-2):138-47. PubMed ID: 22465413
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells.
Slowing II; Wu CW; Vivero-Escoto JL; Lin VS
Small; 2009 Jan; 5(1):57-62. PubMed ID: 19051185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
